Evidence (lenvatinib): A phase III, randomized, double-blind, placebo-controlled study (SELECT [NCT01321554]) evaluated the activity of lenvatinib in patients with progressive, iodine-refractory, differentiated thyroid cancer.[22] In this trial, 261 patients were randomly assigned to receive lenvatinib (24 mg every day), and 131 patients were randomly assigned to receive placebo
One of the photoproductsconsequence of defluorinationproves this type of photoreaction is common for trifluoromethyl compounds (in the case of fluphenazine)
doi: 10.1037/com0000051 27 ClarkA
CrossRef Heart rate variability in people with metabolic syndrome Kostiantyn Apykhtin, Svitlana Drozdovska, Olha Hurenko, Anastasiia Nahorna, Anatoly Pisaruk, Yuliia Panchenko, Olena Andrieieva JOURNAL OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE.2023
Diferentes formas de L-carnitina Efecto de la L-carnitina Dosis de L-carnitina L-carnitina en los alimentos Absorcin y metabolismo de la carnitina Deficiencia de L-carnitina L-carnitina y la funcin cerebral L-carnitina y la fertilidad masculina L-carnitina y rendimiento atltico L-carnitina y el corazn L-carnitina y enfermedades arteriales perifricas L-carnitina y el proceso de envejecimiento L-carnitina y diabetes tipo II L-carnitina - VIH y SIDA L-carnitina e insuficiencia renal (fallo renal) L-carnitina y cncer Quin necesita L-carnitina
